Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 41,571	$ 9,446
Accounts receivable	242	102
Prepaid expenses and other current assets	1,060	1,044
Current deposits	85	65
Total current assets	42,958	10,657
Property and equipment, net	50	117
Operating lease right-of-use assets	156	244
Total assets	43,164	11,018
Current liabilities:
Accounts payable and accrued expenses	6,226	10,242
Current portion of operating lease liabilities	181	169
Current portion of contract liabilities	17	17
Current portion of notes payable	0	191
Total current liabilities	6,424	10,619
Contract liabilities, net of current portion	18,669	18,669
Operating lease liabilities, net of current portion	32	169
Total liabilities	25,251	29,567
Commitments and contingencies
Redeemable noncontrolling interest	0	6,131
Stockholders’ equity (deficit):
Additional paid-in capital	311,060	256,335
Accumulated deficit	(296,084)	(281,042)
Total stockholders’ equity (deficit) attributable to vTv Therapeutics Inc.	15,008	(24,680)
Noncontrolling interest	2,905	0
Total stockholders’ equity (deficit)	17,913	(24,680)
Total liabilities, redeemable noncontrolling interest and stockholders’ equity (deficit)	43,164	11,018
Related Party
Current liabilities:
Warrant liability, related party	82	110
Nonrelated Party
Current liabilities:
Warrant liability, related party	44	0
Class A Common Stock
Stockholders’ equity (deficit):
Common stock value	26	21
Class B Common Stock
Stockholders’ equity (deficit):
Common stock value	$ 6	$ 6